Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates

Stock Information for Spectrum Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Spectrum Pharmaceuticals Inc.

Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction
Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote "FOR" Proposed Transaction with Assertio Holdings, Inc.
IMPORTANT ALERT: Halper Sadeh LLC Investigates FOCS, ASRT, MDWT, SPPI
Moore Kuehn Encourages SYNH, SPPI, ARNC and EMBK Investors to Contact Law Firm
SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI
Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.